Negative-balance isolated pelvic perfusion in patients with incurable symptomatic rectal cancer: results and drug dose correlation to adverse events.
CONCLUSION: NIPP may offer the safe delivery of high-dose regional chemotherapy (MTD of 190 mg/m(2) cisplatin) with negligible AEs and effective control of tumor growth in patients with incurable rectal cancer.
PMID: 24097815 [PubMed - as supplied by publisher]
Source: Acta Radiologica - Category: Radiology Authors: Murata S, Onozawa S, Kim C, Tajima H, Kimata R, Uchida E, Kumita SI Tags: Acta Radiol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Neurology | Perfusion | Radiology | Rectal Cancers | Study | Toxicology | Women